尾島 英知

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Cholangiocarcinoma 74%
3. Neoplasms 49%
4. Liver 36%
5. Biliary Tract 30%
6. Genome 24%
7. Biliary Tract Neoplasms 24%
8. Carcinoma 22%
9. Hepatectomy 21%
10. DNA Methylation 19%
11. Bile Duct Neoplasms 19%
12. Bile Ducts 18%
13. Margins of Excision 17%
14. Mutation 16%
15. Liver Neoplasms 15%
16. Fatty Liver 15%
17. gemcitabine 14%
18. Survival 13%
19. Recurrence 11%
20. Neoplasm Metastasis 11%
21. Whole Genome Sequencing 10%
22. Genes 10%
23. Cell Line 10%
24. Proteomics 10%
25. Adenocarcinoma 9%
26. Carcinoma, Intraductal, Noninfiltrating 9%
27. Pancreas 9%
28. Gallbladder Neoplasms 8%
29. Pancreaticoduodenectomy 8%
30. Axitinib 8%
31. Carcinogenesis 8%
32. Therapeutics 8%
33. Pancreatic Ducts 8%
34. Carcinosarcoma 7%
35. Klatskin Tumor 7%
36. Biomarkers 7%
37. Hepatocytes 7%
38. Vascular Endothelial Growth Factor A 7%
39. Proteins 7%
40. ErbB Receptors 7%
41. Intrahepatic Bile Ducts 7%
42. Catenins 7%
43. Organoids 7%
44. Japan 7%
45. Exome 7%
46. Growth 7%
47. Epigenome 6%
48. Phenotype 6%
49. Right Ventricular Hypertrophy 6%
50. Chromatin 6%